Disbrow Joshua R. 4
4 · AYTU BIOPHARMA, INC · Filed Dec 21, 2022
Insider Transaction Report
Form 4
Disbrow Joshua R.
Chief Executive Officer
Transactions
- Purchase
Common Stock
2022-12-19$0.22/sh+112,371$25,047→ 1,231,877 total
Footnotes (1)
- [F1]The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.213 to $0.23, inclusive. The reporting person undertakes to provide to AYTU Biopharma, Inc., any security holder of AYTU Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.